HELP     Sign In

15q11.1-q11.2CNV Type: Duplication


Largest CNV size: 2155534 bp

Statistics Box:
Number of Reports: 7



Summary Information

A duplication within this region was one of several CNVs identified in a case with developmental delay/intellectual disability (Chilian et al., 2013).

Additional Locus Information

Genome browsers

USCS Symbol             NCBI Symbol

Decipher

            Decipher Symbol

References

Major Reports

Title
Author, Year
Report Class
CNV Type

No Major Reports

Minor Reports

Title
Author, Year
Report Class
CNV Type
Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci.
Duplication
The clinical utility of molecular karyotyping for neurocognitive phenotypes in a consanguineous population.
Duplication
Recurrent 15q11.2 BP1-BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders.
Deletion
Integrative Variation Analysis Reveals that a Complex Genotype May Specify Phenotype in Siblings with Syndromic Autism Spectrum Disorder.
Deletion
NA
Deletion
NA
Deletion
NA
Deletion

Cases

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 al-qattan_14_DD/ID/ASD/ADHD/EP_discovery_cases
 Retrospective chart review of patients (n=584) with a neurocognitive phenotype (mainly referred from pediatric neurology clinics) seen by a single clinical geneticist from September 2007 to July 2013
 584
 Inclusion criteria: presence of a neurocognitive phenotype (i.e., syndromic and non-syndromic cases of developmental delay, autism, intellectual disability, and epilepsy) with a normal karyotype
 N/A
 N/A
 2328576
 0
 1
 1
 chilian_13_DD/ID_discovery_cases
 Patient, born to healthy non-consanguineous parents with no family history of ID, referred at 18 months of age for marked psychomotor and developmental delay; patient carries balanced de novo triple translocation t(11;17;19)(q13.3;q25.1;q13.42)dn with breakpoint disrupting the SHANK2 gene.
 1
 Severe DD/ID, language impairment, behavioral abnormalities
 5 yrs.
 Male
 2155534
 0
 1
 1
 cucinotta_23_ASD_discovery_cases
  NA NA
 Idiopathic ASD patients from 310 families (263 simplex and 47 multiplex) recruited at the Service for Neurodevelopmental Disorders at Campus Bio-Medico University Hospital in Rome (Italy) and at the Interdepartmental Program Autism 090 of the G. Martino University Hospital (Messina, Italy) between the years 2012 and 2019.
 329
 Clinical diagnosis of ASD based on fulfilling DSM-5 criteria and confirmed using ADOS-2 and ADI-R.
 NA
 84.19% Male
 2352463
 1
 0
 1
 maini_18_ASD/DD/ID_discovery_cases
  NA NA
 Patients evaluated at the Clinical Genetics Unit of Arcispedale Santa Maria Nuova, AUSL-IRCCS of Reggio Emilia that were investigated through aCGH between 2005 and 2016
 293
 Cases presented with one or more neurodevelopmental disorders (NDD), multiple congenital anomalies (MCA), and/or dysmorphic features. Most frequent neurodevelopmental diagnoses include language delay (78.5%), intellectual disability (66.4%), motor delay (50.7%), and ASD (13.9%); dysmorphic features were also frequently observed (52.7%)
 Mean age, 7 yrs. (range, 1 mo.-29 yrs.)
 57.5% Male
 2700000
 1
 0
 1
 mazzonetto_24_ASD/DD/ID_discovery_cases
  NA NA
 Patients from a total of 15 non-profit organizations and university centers located in different states of Brazil who were enrolled between July 2021 and June 2022 and referred with unexplained neurodevelopmental delay/intellectual disability, autism spectrum disorder (ASD), and/or multiple congenital anomalies.
 1363
 "95% of individuals in this cohort reported with the HPO phenotype ""Abnormality of the nervous system"" (HP:0000707); the HPO phenotypes ""Intellectual disability"" (HP:0001249; 36%), ""Global developmental delay"" (HP:0001263; 32%), and ""Autism"" (HP:0000717; 28%) were the most frequently reported phenotype subcategories within this subset of individuals."
 
 63.17% Male
 3039042
 2
 0
 2
 picinelli_16_ASD/ADHD/DD/ID_discovery_cases
 Patients with 15q11.2 CNVs assessed in the Child and Adolescent Neuropsychiatry Unit of Campus Bio-Medico University Hospital in Rome, Italy, from an original cohort of 243 subjects affected by neurodevelopmental disorders and their first-degree relatives
 6
 Neuropsychiatric diagnosis made according to DSM-IV criteria. Instruments used for data collection were Leiter International Performance Scale-Revised (Leiter-R), Wechsler Intelligence Scale for Children-3rd Revision (WISC III), Wechsler Adult Intelligence Scale-3rd edition (WAIS-III), Autism Diagnostic Observation Schedule (ADOS), Autism and Asperger Diagnostic Scale-Revised (RAADS-R), Autism Diagnostic Interview-Revised (ADI-R), Vineland Adaptive Behavior Scales (VABS), and the Child Behavior Checklist (CBCL/6-18)
 Range, 8-19 yrs.
 83.33% Male
 2077054
 1
 0
 1
 reis_17_ASD/ID_discovery_cases
 Two siblings (one male, one female) with syndromic ASD who participated in an ongoing exome research study at the Autism Spectrum Disorder Program Clinic of the Psychiatric Institute of the University of Sao Paulo School of Medicine
 2
 The male sibling met criteria for a diagnosis of ASD according to DSM-5 criteria (CARS score 33.5), while the female sibling was diagnosed with intellectual disability and syndromic features (CARS score 24.0)
 Range, 29-33 yrs.
 50% Male
 1994148
 1
 0
 1

Controls

No Control Data Available

Cases

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
 al-qattan_14_DD/ID/ASD/ADHD/EP_discovery_cases
  Saudi Arabia
 Array SNP
  Affymetrix 6.0, Affymetrix Cyto-V2, Affymetrix CytoScan HD
 HMM
 Affymetrix GeneChip Command Console v.1.2, Affymetrix ChAS version Cyto 2.0.0.195
 None
 chilian_13_DD/ID_discovery_cases
  Germany
 aCGH
  Agilent Human Genome CGH Microarray 244A
 
 
 None
 cucinotta_23_ASD_discovery_cases
  Italy
 aCGH
  Agilent SurePrint 4180K
 ADM-2
 Agilent Feature Extraction v.10.7., Agilent Cytogenomic Software v.4.0.3.12.
 None
 maini_18_ASD/DD/ID_discovery_cases
  Italian
 aCGH, array SNP
  Multiple platforms, including Agilent and Affymetrix arrays (8x60K oligochips since 2012)
 
 
 None
 mazzonetto_24_ASD/DD/ID_discovery_cases
  Brazil
 Low-pass WGS
  Illumina NovaSeq 6000
 SNP-FASST2 (HMM)
 BioDiscovery NxClinical
 
 picinelli_16_ASD/ADHD/DD/ID_discovery_cases
  Italy
 aCGH
  Agilent SurePrint G3 4x180K
 ADM-2
 Agilent Cytogenomic Software v2.7
 None
 reis_17_ASD/ID_discovery_cases
  Brazil
 aCGH
  Agilent 180K
 ADM-2
 Agilent Feature Extraction 10.7.3.1
 None

Controls

No Control Data Available

Cases

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  al-qattan_14_DD/ID/ASD/ADHD/EP_discovery_cases-case11DG0629
 N/A
 F
 Developmental delay
 Global developmental delay with dysmorphic features, short stature, congenital strabismus with limited eye movements, prominent distal phalangeal bones of both hands. Consanguineous parents.
 Global developmental delay
 19970370
 22216247
  2245878
 GRCh38
 Duplication
 No
  chilian_13_DD/ID_discovery_cases-case1
 5 yrs.
 M
 Developmental delay/intellectual disability
 Patient referred at 18 months for marked psychomotor and developmental delay. Karyotype: 46, XY, t(11;17;19)(q13.3;q25.1;q13.42)dn; translocation with breakpoints within the SHANK2 and UBE2O genes. Birth/neonatal history: duing pregnancy mother had cervical cancer (treated after birth), born at 39 weeks gestation by C-section; birth weight -0.23 SD, length -0.83 SD, OFC +0.7 SD; uneventful perinatal adaption; ventricular septal defect diagnosed at 2 months. Developmental milestones: psychomotor retardation noted at 1.5 years; sat independently at 8 months, began to walk with support at 2.5 years, independent walking at 3.5 years, not toilet trained at 5 years of age. Language and communication evaluation: no spoken language. Motor and musculoskeletal evaluation: ataxia, able to stand with support. Behavioral/psychiatric evaluation: anxious, exhibited habit disorder with stereotypic movements, decreased sensitivity to pain, often caused self-injury. EEG: increased irregular activity. Brain imaging: normal by ultrasound. Visual and auditory evaluation: normal. Sleep disturbances: serious sleeping disturbances. Other features: elevated alkaline phosphatase, lactate dehydrogenase, and serum magnesium levels. Dysmorphic features: coarse face with facial dysmorphism, broad thorax, clinodactyly of 2nd and 3rd toes. Growth parameters: weight of 19.3 kg (+0.1 SD), length of 105 cm (-1.0 SD) and OFC of 51 cm (0 SD) at 5 years of age. Family history: second child of healthy non-consanguineous parents; no family history of miscarriages, ID, or alcohol exposure in utero.
 Severe DD/ID. Evaluation at age of 1.5 years: Brunet-Lezine development test showed delay in movements, coordination, communication, and social skills; psychomotor development corresponded to 9 months, development quotient of 48; Bayley Scales of Infant Development gave Developmental Index score of 84.
 20217843
 22290679
  2072837
 GRCh38
 Duplication
 No
  cucinotta_23_ASD_discovery_cases-case12
  NA NA
 NA
 NA
 ASD
 Clinical diagnosis of ASD based on fulfilling DSM-5 criteria and confirmed using ADOS-2 and ADI-R.
 
 20481702
 22834164
  2352463
 GRCh37
 Deletion
 No
  maini_18_ASD/DD/ID_discovery_cases-case_unknown34
  NA NA
 N/A
 N/A
 NDD/MCA/dysmorphic features
 CNV was identified in an individual with one or more neurodevelopmental disorders (NDD), multiple congenital anomalies (MCA), and/or dysmorphic features (detailed clinical information was not available). CNV classified as variant of unknown significance-likely pathogenic (VOUS-LP)
 
 20276450
 22308242
  2031793
 GRCh38
 Deletion
 No
  mazzonetto_24_ASD/DD/ID_discovery_cases-caseDECIPHER530566
  NA NA
 
 M
 Developmental delay
 Global developmental delay (HP:0001263), abnormal facial shape (HP:0001999)
 
 20400820
 23439861
  3039042
 GRCh38
 Deletion
 No
  mazzonetto_24_ASD/DD/ID_discovery_cases-caseDECIPHER530567
  NA NA
 
 F
 MCA
 Abnormal facial shape (HP:0001999), orofacial cleft (HP:0000202)
 
 20450820
 23139861
  2689042
 GRCh38
 Deletion
 No
  picinelli_16_ASD/ADHD/DD/ID_discovery_cases-patient3
 N/A
 M
 Developmental delay
 Birth/neonatal history: born after artificial insemination by ICSI. Developmental milestones: displayed neurodevelopmental delay at 1 year. Motor and musculoskeletal evaluation: hypotonia. Behavioral/psychiatric evaluation: self-injurious behavior. Family history: paternal uncle diagnosed with Asperger syndrome.
 Developmental delay (TIQ score of 54)
 20276449
 22270805
  1994357
 GRCh38
 Deletion
 No
  reis_17_ASD/ID_discovery_cases-case2
 29 yrs.
 F
 Intellectual disability
 Birth/neonatal history: reported abdominal pain and vaginal bleeding during pregnancy; delivery by C-section; birth weight 4140 g, length 51 cm. Developmental milestones: first steps at 18 months of age, had not begun to produce speech until after 2 years of age. Language and communication evaluation: able to understand simple and some complex commands, uses imitation, verbal with simple sentences with substitutions (mostly "r" for "l"). Motor and musculoskeletal evaluation: large hands, clinodactyly, large feet, hypoplastic nails, kyphosis, exhibited some difficulty standing on one foot, gait was symmetric with large steps. Behavioral/psychiatric evaluation: CARS score of 24.0; presented eye contact and initiated interaction in an inappropriate form, quite puerlie with no functionality; psychomotor agitation (mainly in the mornings); occasionally aggressive, but affectionate and gentle most of the time; liked playing with other children; sometimes exhibited periods of inappropriate, hypersocial behavior and periods during which she could not stop talking; sleep difficulties. Dysmorphic features: macrocephaly, long face, low posterior hairline, arched eyebrows, long eyelashes, wide nasal bridge, thin lips, crowded teeth, low-set ears, malformed ears. Growth parameters: height of 183 cm, weight of 91.5 kg, OFC 59 cm. Karyotype: case has a paternally-inherited balanced translocation [der(8)t(4;8)(p16.3;p23.1). Family history: born to nonconsanguineous parents; no family history of ASD, other psychiatric disorders, intellectual disability, or malformations.
 Diagnosed with intellectual disability in 1992
 20359355
 22270805
  1911451
 GRCh38
 Deletion
 No

Controls

No Control Data Available

Cases

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
 al-qattan_14_DD/ID/ASD/ADHD/EP_discovery_cases-case11DG0629
 
 
 Unknown
 Unknown
 Unknown
 IGHV1OR15-2,IGHV3OR15-7,IGHD5OR15-5A,IGHD4OR15-4A,IGHD3OR15-3A,IGHD2OR15-2A,IGHD1OR15-1A,FAM30B,BCAR1P1,RN7SL584P,BMS1P15,GOLGA6L6,GOLGA8CP,RN7SL759P,IGHV1OR15-6,RNU6-498P,GRAMD4P5,MIR3118-2,RNU6-749P,ZNF519P2,MIR5701-1,OR11J2P,OR11J5P,IGHD5OR15-5B,IGHD4OR15-4B,IGHD3OR15-3B,IGHD2OR15-2B,IGHD1OR15-1B,BCAR1P2,RN7SL400P,BMS1P16,RNU6-1235P,CXADRP2,GRAMD4P6,MIR3118-3,MIR5701-2,LINC02203,OR11K1P,MIR3118-4,RNU6-631P,ZNF519P3,MIR5701-3,OR11J7P,OR11J6P,OR11H3P,OR4Q1P,OR4H6P,OR4M2,OR4N4,OR4N3P,RPS8P10,IGHV1OR15-1,IGHV1OR15-3,IGHV4OR15-8,IGHV1OR15-4,CHEK2P2,SPATA31E2P,NBEAP1,NF1P1,FAM30C,POTEB3,POTEB,NF1P2,HERC2P3,POTEB2,NF1P9,LINC01193
 
 chilian_13_DD/ID_discovery_cases-case1
 
 
 Unknown
 Possibly simplex (no info on 1st child)
 Unknown
 GOLGA6L6,GOLGA8CP,RN7SL759P,IGHV1OR15-6,RNU6-498P,GRAMD4P5,MIR3118-2,RNU6-749P,ZNF519P2,MIR5701-1,OR11J2P,OR11J5P,IGHD5OR15-5B,IGHD4OR15-4B,IGHD3OR15-3B,IGHD2OR15-2B,IGHD1OR15-1B,BCAR1P2,RN7SL400P,BMS1P16,RNU6-1235P,CXADRP2,GRAMD4P6,MIR3118-3,MIR5701-2,LINC02203,OR11K1P,MIR3118-4,RNU6-631P,ZNF519P3,MIR5701-3,OR11J7P,OR11J6P,OR11H3P,OR4Q1P,OR4H6P,OR4M2,OR4N4,OR4N3P,RPS8P10,IGHV1OR15-1,IGHV1OR15-3,IGHV4OR15-8,IGHV1OR15-4,MIR1268A,CHEK2P2,SPATA31E2P,NBEAP1,NF1P1,FAM30C,POTEB3,POTEB,NF1P2,HERC2P3,POTEB2,NF1P9,LINC01193
 
 cucinotta_23_ASD_discovery_cases-case12
 
 
 De novo
 
 
 NBEAP1,IGHD3OR15-3B,IGHD5OR15-5B,OR4H6P,IGHD1OR15-1B,IGHD4OR15-4B,IGHV1OR15-6,IGHD2OR15-2B,IGHV4OR15-8,ABCB10P1,OR11J2P,OR11H3P,OR11J1P,OR11K1P,OR4Q1P,TUBGCP5,OR4N4,GOLGA6L1,HERC2P3,IGHV1OR15-1,OR4N3P,OR4M2,NF1P2,OR11J5P,IGHV1OR15-4,IGHV1OR15-3,CHEK2P2,CXADRP2,SPATA31E2P,GOLGA6L6,BMS1P16,GOLGA8CP,ELMO2P1,GOLGA8DP,POTEB2,MIR1268A,NF1P1,MIR3118-4,MIR4509-1,MIR5701-1,MIR5701-2,GRAMD4P6,GRAMD4P5,POTEB,RNU6-631P,RN7SL759P,RN7SL400P,RNU6-1235P,RNU6-749P,RNU6-498P,RN7SL545P
 
 maini_18_ASD/DD/ID_discovery_cases-case_unknown34
 
 
 Maternal
 Unknown
 Unknown
 GOLGA6L6,GOLGA8CP,RN7SL759P,IGHV1OR15-6,RNU6-498P,GRAMD4P5,MIR3118-2,RNU6-749P,ZNF519P2,MIR5701-1,OR11J2P,OR11J5P,IGHD5OR15-5B,IGHD4OR15-4B,IGHD3OR15-3B,IGHD2OR15-2B,IGHD1OR15-1B,BCAR1P2,RN7SL400P,BMS1P16,RNU6-1235P,CXADRP2,GRAMD4P6,MIR3118-3,MIR5701-2,LINC02203,OR11K1P,MIR3118-4,RNU6-631P,ZNF519P3,MIR5701-3,OR11J7P,OR11J6P,OR11H3P,OR4Q1P,OR4H6P,OR4M2,OR4N4,OR4N3P,RPS8P10,IGHV1OR15-1,IGHV1OR15-3,IGHV4OR15-8,IGHV1OR15-4,MIR1268A,CHEK2P2,SPATA31E2P,NBEAP1,NF1P1,FAM30C,POTEB3,POTEB,NF1P2,HERC2P3,POTEB2,NF1P9,LINC01193
 
 mazzonetto_24_ASD/DD/ID_discovery_cases-caseDECIPHER530566
 
 
 Unknown
 
 
 NBEAP1,IGHD3OR15-3B,OR4H6P,IGHD4OR15-4B,IGHV4OR15-8,IGHD2OR15-2B,IGHV1OR15-6,IGHD1OR15-1B,IGHD5OR15-5B,ABCB10P1,OR11J2P,NIPA2,OR4Q1P,OR11H3P,OR11K1P,NIPA1,TUBGCP5,GOLGA8IP,OR4N4,HERC2P3,GOLGA6L2,GOLGA6L1,WHAMMP3,RPS8P10,LINC01193,IGHV1OR15-1,OR4N3P,OR4M2,HERC2P2,GOLGA8EP,OR11J5P,NF1P2,GOLGA6L22,CXADRP2,SPATA31E3P,SPATA31E2P,IGHV1OR15-4,IGHV1OR15-3,LINC02203,FAM30C,BMS1P16,GOLGA8S,GOLGA6L6,ELMO2P1,GOLGA8CP,GOLGA8DP,HERC2P7,ZNF519P3,POTEB2,OR11J7P,ZNF519P2,OR11J6P,MIR1268A,NBEAP4,NF1P1,LONRF2P4,LONRF2P3,MIR3118-2,MIR3118-3,MIR3118-4,MIR4509-1,BCAR1P2,GRAMD4P6,PDCD6IPP1,MIR5701-2,GRAMD4P5,MIR5701-1,POTEB,NF1P9,POTEB3,MIR5701-3,OR4N4C,OR4H6BP,RN7SL495P,RN7SL106P,RN7SL759P,RNU6-631P,RN7SL536P,RNU6-749P,RNU6-1235P,RN7SL400P,RNU6-498P,RN7SL545P,HERC2P6,OR11K1BP,OR4N3BP,OR1Q1BP,OR4M2B,CYFIP1
 
 mazzonetto_24_ASD/DD/ID_discovery_cases-caseDECIPHER530567
 
 
 Unknown
 
 
 NBEAP1,IGHD3OR15-3B,OR4H6P,IGHD4OR15-4B,IGHV4OR15-8,IGHD2OR15-2B,IGHV1OR15-6,IGHD1OR15-1B,IGHD5OR15-5B,OR11J2P,NIPA2,OR4Q1P,OR11H3P,OR11K1P,NIPA1,TUBGCP5,GOLGA8IP,OR4N4,HERC2P3,GOLGA6L1,WHAMMP3,RPS8P10,LINC01193,IGHV1OR15-1,OR4N3P,OR4M2,HERC2P2,GOLGA8EP,OR11J5P,NF1P2,GOLGA6L22,CXADRP2,SPATA31E3P,SPATA31E2P,IGHV1OR15-4,IGHV1OR15-3,LINC02203,FAM30C,BMS1P16,GOLGA6L6,ELMO2P1,GOLGA8CP,HERC2P7,ZNF519P3,POTEB2,OR11J7P,ZNF519P2,OR11J6P,MIR1268A,NBEAP4,NF1P1,LONRF2P4,LONRF2P3,MIR3118-2,MIR3118-3,MIR3118-4,BCAR1P2,GRAMD4P6,PDCD6IPP1,MIR5701-2,GRAMD4P5,MIR5701-1,POTEB,NF1P9,POTEB3,MIR5701-3,OR4N4C,OR4H6BP,RN7SL495P,RN7SL759P,RNU6-631P,RNU6-749P,RNU6-1235P,RN7SL400P,RNU6-498P,RN7SL545P,OR11K1BP,OR4N3BP,OR1Q1BP,OR4M2B,CYFIP1
 
 picinelli_16_ASD/ADHD/DD/ID_discovery_cases-patient3
 
 
 Both parents
 Multi-generational
 Unknown
 GOLGA6L6,GOLGA8CP,RN7SL759P,IGHV1OR15-6,RNU6-498P,GRAMD4P5,MIR3118-2,RNU6-749P,ZNF519P2,MIR5701-1,OR11J2P,OR11J5P,IGHD5OR15-5B,IGHD4OR15-4B,IGHD3OR15-3B,IGHD2OR15-2B,IGHD1OR15-1B,BCAR1P2,RN7SL400P,BMS1P16,RNU6-1235P,CXADRP2,GRAMD4P6,MIR3118-3,MIR5701-2,LINC02203,OR11K1P,MIR3118-4,RNU6-631P,ZNF519P3,MIR5701-3,OR11J7P,OR11J6P,OR11H3P,OR4Q1P,OR4H6P,OR4M2,OR4N4,OR4N3P,RPS8P10,IGHV1OR15-1,IGHV1OR15-3,IGHV4OR15-8,IGHV1OR15-4,MIR1268A,CHEK2P2,SPATA31E2P,NBEAP1,NF1P1,FAM30C,POTEB3,POTEB,NF1P2,HERC2P3,POTEB2,NF1P9,LINC01193
 
 reis_17_ASD/ID_discovery_cases-case2
 
 
 De novo
 Multiplex
 Not segregated
 GOLGA6L6,GOLGA8CP,RN7SL759P,IGHV1OR15-6,RNU6-498P,GRAMD4P5,MIR3118-2,RNU6-749P,ZNF519P2,MIR5701-1,OR11J2P,OR11J5P,IGHD5OR15-5B,IGHD4OR15-4B,IGHD3OR15-3B,IGHD2OR15-2B,IGHD1OR15-1B,BCAR1P2,RN7SL400P,BMS1P16,RNU6-1235P,CXADRP2,GRAMD4P6,MIR3118-3,MIR5701-2,LINC02203,OR11K1P,MIR3118-4,RNU6-631P,ZNF519P3,MIR5701-3,OR11J7P,OR11J6P,OR11H3P,OR4Q1P,OR4H6P,OR4M2,OR4N4,OR4N3P,RPS8P10,IGHV1OR15-1,IGHV1OR15-3,IGHV4OR15-8,IGHV1OR15-4,MIR1268A,SPATA31E2P,NBEAP1,NF1P1,FAM30C,POTEB3,POTEB,NF1P2,HERC2P3,POTEB2,NF1P9,LINC01193
 

Controls

No Control Data Available
No Animal Model Data Available
HELP
Copyright © 2017 MindSpec, Inc.